re: Ann: Appendix 4C - 2nd quarter and Invest...
All in all looks good! However a couple of things concern me,and maybe they shouldnt....
Highlights: • $5.3 million received from issue of shares and options • Recruited new management team • Corporate restructure focusing on US commercialisation • Preparation for iSonea trading on US OTCQX from 3 January 2012 (Symbol: ISOAY) • Protocol finalised for US WheezoMeter study to support non-Rx submission to FDA • Mobile health product development initiated for smartphone asthma management app v1.0 • US asthma consumer quantitative research (n=369) conducted on app usage & monitoring
Bullet point 2 states new management team under THIS quarters highlights(this occured in second quarter) And $5.3 mill raised but cash at end of quarter is ONLY $3.8 WHAT DID WE DO WITH THE REST????? Its only been 5 weeks????
ISN Price at posting:
12.0¢ Sentiment: LT Buy Disclosure: Held